Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 189 of 189 entries
View as:

Study of Apremilast in Atopic or Contact Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00931242 Org: User:
Start: 06/30/09 End: 03/31/10 Due: 03/31/11

Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation

Phase: N/A Priority: Normal
NCT ID: NCT00871624 Org: User:
Start: 03/31/09 End: 02/28/13 Due: 02/28/14

mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM

Phase: N/A Priority: Normal
NCT ID: NCT05597943 Org: User:
Start: 05/01/23 End: 02/01/25 Due: 02/01/26

Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06253104 Org: User:
Start: 02/19/24 End: 12/31/26 Due: 12/31/27

Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip

Phase: N/A Priority: Normal
NCT ID: NCT00868088 Org: User:
Start: 07/31/09 End: 09/30/10 Due: 09/30/11

Single-operator Ultrasound-guided IV Placement by Emergency Nurses

Phase: N/A Priority: Normal
NCT ID: NCT01439113 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00129974 Org: User:
Start: 08/31/05 End: 10/31/06 Due: 10/31/07

Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram

Phase: N/A Priority: Normal
NCT ID: NCT00562861 Org: User:
Start: 11/30/07 End: 07/31/14 Due: 07/31/15

Prospective Study to Validate the Imaging Biomarker for NCP (R33)

Phase: N/A Priority: Normal
NCT ID: NCT05653921 Org: User:
Start: 12/16/22 End: 07/14/25 Due: 07/14/26

Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02107482 Org: User:
Start: 12/31/11 End: 12/31/14 Due: 12/31/15

Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

Phase: N/A Priority: Normal
NCT ID: NCT04838223 Org: User:
Start: 07/02/21 End: 07/31/25 Due: 07/31/26

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT05626530 Org: User:
Start: 02/02/23 End: 12/15/25 Due: 12/15/26

H+ Mobilization With Dialysate Bicarbonate Variation

Phase: N/A Priority: Normal
NCT ID: NCT04020757 Org: User:
Start: 06/12/19 End: 11/30/19 Due: 11/30/20

Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests

Phase: N/A Priority: Normal
NCT ID: NCT04125134 Org: User:
Start: 10/03/19 End: 12/31/25 Due: 12/31/26